Alcon shares fell 8.8% over the past year as cataract market growth missed expectations amid increased competition in premium lenses.
SGA Global Growth Strategy exited its position in Alcon Inc. (ALC) during Q2 2026, citing subdued demand for cataract procedures and rising competition in premium intraocular lenses. Alcon closed at $73.63 on August 21, 2026, with a market capitalization of $36.68 billion.
Alcon reported 6% constant-currency revenue growth and 16%+ EPS growth in Q1, below the 7% expectation. The company remains the market leader in eye care but is expected to lose share in premium lenses, where it previously held over 80% of the market. Cataract and contact lens demand remains weak, offset partially by strong product launches.
Shares of Alcon rose 9.44% over the past month but declined 8.83% over the last 52 weeks, reflecting broader market pressures and competitive challenges.